YY1 expression predicts favourable outcome in follicular lymphoma.
dc.contributor.author | Naidoo, Khimara | |
dc.contributor.author | Clay, V | |
dc.contributor.author | Hoyland, J A | |
dc.contributor.author | Swindell, Ric | |
dc.contributor.author | Linton, Kim M | |
dc.contributor.author | Illidge, Timothy M | |
dc.contributor.author | Radford, John A | |
dc.contributor.author | Byers, RJ | |
dc.date.accessioned | 2012-01-09T22:43:58Z | |
dc.date.available | 2012-01-09T22:43:58Z | |
dc.date.issued | 2011-02 | |
dc.identifier.citation | YY1 expression predicts favourable outcome in follicular lymphoma. 2011, 64 (2):125-9 J. Clin. Pathol. | en |
dc.identifier.issn | 1472-4146 | |
dc.identifier.pmid | 21109702 | |
dc.identifier.doi | 10.1136/jcp.2010.078188 | |
dc.identifier.uri | http://hdl.handle.net/10541/201091 | |
dc.description.abstract | Follicular lymphoma is the second most common type of non-Hodgkin's lymphoma worldwide. The majority of patients diagnosed as having follicular lymphoma have an indolent form of the disease, but a subset of patients have aggressive disease with a shorter survival interval. Optimal treatment stratification requires a distinction between these two groups, though there are presently few prognostic biomarkers available. The transcription factor YY1 has been shown to play an important role in cancer biology. The authors have previously reported a correlation of Yin Yang 1 (YY1) mRNA levels with survival in FL. This study aimed to validate these findings at the protein level. | |
dc.language.iso | en | en |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Female | |
dc.subject.mesh | Follow-Up Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Kaplan-Meier Estimate | |
dc.subject.mesh | Ki-67 Antigen | |
dc.subject.mesh | Lymphoma, Follicular | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Neoplasm Proteins | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Tumor Markers, Biological | |
dc.subject.mesh | YY1 Transcription Factor | |
dc.title | YY1 expression predicts favourable outcome in follicular lymphoma. | en |
dc.type | Article | en |
dc.contributor.department | School of Cancer and Enabling Sciences, Faculty of Medical and Human Sciences, The University of Manchester, Manchester, UK. | en |
dc.identifier.journal | Journal of Clinical Pathology | en |
html.description.abstract | Follicular lymphoma is the second most common type of non-Hodgkin's lymphoma worldwide. The majority of patients diagnosed as having follicular lymphoma have an indolent form of the disease, but a subset of patients have aggressive disease with a shorter survival interval. Optimal treatment stratification requires a distinction between these two groups, though there are presently few prognostic biomarkers available. The transcription factor YY1 has been shown to play an important role in cancer biology. The authors have previously reported a correlation of Yin Yang 1 (YY1) mRNA levels with survival in FL. This study aimed to validate these findings at the protein level. |
This item appears in the following Collection(s)
-
All Christie Publications
-
Medical Oncology
Medical Oncology